Edition:
India

Recordati Industria Chimica e Farmaceutica SpA (RECI.MI)

RECI.MI on Milan Stock Exchange

37.44EUR
17 Jan 2018
Change (% chg)

€-0.48 (-1.27%)
Prev Close
€37.92
Open
€37.00
Day's High
€37.66
Day's Low
€36.80
Volume
459,970
Avg. Vol
339,675
52-wk High
€40.80
52-wk Low
€26.10

Chart for

About

Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central... (more)

Overall

Beta: 0.54
Market Cap(Mil.): €8,275.08
Shares Outstanding(Mil.): 209.13
Dividend: 0.35
Yield (%): 1.77

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.44
EPS (TTM): -- -- --
ROI: -- 14.85 10.61
ROE: -- 16.31 14.21

BRIEF-Recordati Q3 net profit up at EUR ‍​72.8 mln, confirms FY targets

* Q3 NET PROFIT EUR ‍​72.8 MILLION VERSUS EUR 59.6 MILLION YEAR AGO

26 Oct 2017

BRIEF-Recordati H1 net profit up at EUR 147.0 mln, raises FY 2017 targets

July 27 RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA:

27 Jul 2017

BRIEF-Recordati: European Commission approves Reagila as schizophrenia treatment

* EUROPEAN COMMISSION APPROVES REAGILA (CARIPRAZINE) FOR TREATMENT OF SCHIZOPHRENIA Source text: http://bit.ly/2teBSwQ Further company coverage: (Gdynia Newsroom)

19 Jul 2017

Earnings vs. Estimates